NetraMark Holdings Inc AIAI
TSX · Canada · Technology Services
CAD 0.72000.00 (0.00%)
Market open· · CAD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market open· · CAD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Total return, dividends included.
Where the price sits against its 50- and 200-day moving averages.
Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.
NetraAI’s biological and clinical signatures successfully boosted the accuracy of all eight evaluated algorithms across every single dataset testedThe study showed improved performance across conventional machine learning, neural-network and foundation-model (including Fable 5) approaches in schizophrenia, major depressive disorder and pancreatic cancerFindings support what the company believes is the potential of an unbiased discovery-first approach to uncover clinically relevant structure in c
Veteran global finance leader adds institutional investment, capital markets and strategic transaction expertise to NetraMark TORONTO, Sept. 08, 2026 (GLOBE NEWSWIRE) -- NetraMark Holdings Inc. (the "Company" or "NetraMark") (TSX: AIAI) (OTCQB: AINMF) (Frankfurt: PF0), a clinical intelligence company transforming clinical trials with AI-powered precision analytics in the pharmaceutical industry, today announced the appointment of Kevin Felix as Strategic Advisor, strengthening the senior strateg
Virtual corporate presentation available September 11, 2026NetraMark management to hold in-person one-on-one investor meetings in New York City September 14th and 15th TORONTO, Aug. 27, 2026 (GLOBE NEWSWIRE) -- NetraMark Holdings Inc. (the "Company" or "NetraMark") (TSX: AIAI) (OTCQB: AINMF) (Frankfurt: PF0), a clinical intelligence company transforming clinical trials with AI-powered precision analytics in the pharmaceutical industry, today announced its participation in the H.C. Wainwright 28t
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.